Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Oct 15, 2024; 16(10): 4244-4263
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4244
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4244
Figure 4 Investigation of the potential mechanisms of Rho GTPase activating protein 12 in the focal adhesion pathway.
A: Enrichment analysis; B: Focal adhesion pathway scores in various cell types; C: Number of interactions in various cell types; D: Strength of interactions in various cell types. FA: Focal adhesion.
- Citation: Wang XW, Tang YX, Li FX, Wang JL, Yao GP, Zeng DT, Tang YL, Chi BT, Su QY, Huang LQ, Qin DY, Chen G, Feng ZB, He RQ. Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(10): 4244-4263
- URL: https://www.wjgnet.com/1948-5204/full/v16/i10/4244.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i10.4244